Yasubumi Sakakibara Selected Research

Protein Kinase C

6/2022

AI and computational chemistry-accelerated development of an alotaketal analogue with conventional PKC selectivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasubumi Sakakibara Research Topics

Disease

2	GM1 Gangliosidosis (Gangliosidosis GM1) 03/2013 - 05/2009
1	HIV Infections (HIV Infection) 06/2022
1	Neoplasms (Cancer) 06/2022
1	Alzheimer Disease (Alzheimer's Disease) 06/2022
1	Hyperthyroidism 01/2022
1	Hypothyroidism 01/2022
1	Neurocognitive Disorders (Clerambault Syndrome) 09/2020
1	Mucopolysaccharidosis IV (Morquio Syndrome) 03/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2009
1	Gaucher Disease (Gaucher's Disease) 05/2009
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2009

Drug/Important Bio-Agent (IBA)

1	IsoenzymesIBA 06/2022
1	Protein Kinase CIBA 06/2022
1	CholesterolIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	CreatinineIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	migalastatIBA 03/2013
1	GalactosidasesIBA 03/2013
1	5N,6S- (N'- butyliminomethylidene)- 6- thio- 1- deoxygalactonojirimycinIBA 03/2013
1	LigandsIBA 03/2013
1	N-octyl-beta-valienamineIBA 05/2009
1	beta-GlucosidaseIBA 05/2009
1	valienamineIBA 05/2009

Therapy/Procedure

1	Oral Administration 03/2013
1	Therapeutics 05/2009